E Fund Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
E Fund Management's GILD Position: Q2 2026 in Review
E Fund Management increased its Gilead Sciences (GILD) stake by 6.7% in Q2 2026, buying an estimated $445K and bringing the position to 53,836 shares worth $6.8M. The position accounts for 0.15% of the portfolio, ranked #74.
E Fund Management first reported a position in GILD in Q1 2021 and has held it in 19 quarters since. The position peaked at $7.03M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- E Fund Management held 53,836 shares of Gilead Sciences worth $6.8M as of Q2 2026.
- E Fund Management bought 3,378 Gilead Sciences shares in Q2 2026, an estimated $445K.
- Gilead Sciences made up 0.15% of E Fund Management's portfolio in Q2 2026, its #74 holding.
- E Fund Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 19 quarters since.
- E Fund Management's Gilead Sciences position peaked at $7.03M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.